Stéphane Bancel, Moderna CEO (Steven Ferdman/Getty Images)

Mod­er­na plots mR­NA vac­cine fac­to­ry in Aus­tralia that can churn out 100M dos­es per year

Just two months af­ter Mod­er­na an­nounced plans to build a $500 mil­lion mR­NA vac­cine fac­to­ry in Africa, the biotech gi­ant agreed “in prin­ci­ple” yes­ter­day on a new mR­NA vac­cine man­u­fac­tur­ing fa­cil­i­ty — but in­stead of look­ing in the US, Eu­rope or Africa again, Mod­er­na is go­ing to the land down un­der.

While the deal is not set in stone, Mod­er­na said that the biotech and the Aus­tralian gov­ern­ment are com­mit­ted to fi­nal­iz­ing the agree­ment. As for the fi­nan­cial as­pects of the deal, they have not been pub­licly dis­closed.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.